Stock Research for PMCB

PMCB

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PMCB Stock Chart & Research Data

The PMCB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PMCB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PMCB Due diligence Resources & Stock Charts

The PMCB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PMCB Detailed Price Forecast - CNN Money CNN View PMCB Detailed Summary - Google Finance
Yahoo View PMCB Detailed Summary - Yahoo! Finance Zacks View PMCB Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PMCB Trends & Analysis - Trade-Ideas Barrons View PMCB Major Holders - Barrons
NASDAQ View PMCB Call Transcripts - NASDAQ Seeking View PMCB Breaking News & Analysis - Seeking Alpha
Spotlight View PMCB Annual Report - CompanySpotlight.com OTC Report View PMCB OTC Short Report - OTCShortReport.com
TradeKing View PMCB Fundamentals - TradeKing Charts View PMCB SEC Filings - Bar Chart
WSJ View Historical Prices for PMCB - The WSJ Morningstar View Performance/Total Return for PMCB - Morningstar
MarketWatch View the Analyst Estimates for PMCB - MarketWatch CNBC View the Earnings History for PMCB - CNBC
StockMarketWatch View the PMCB Earnings - StockMarketWatch MacroAxis View PMCB Buy or Sell Recommendations - MacroAxis
Bullish View the PMCB Bullish Patterns - American Bulls Short Pains View PMCB Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PMCB Stock Mentions - StockTwits PennyStocks View PMCB Stock Mentions - PennyStockTweets
Twitter View PMCB Stock Mentions - Twitter Invest Hub View PMCB Investment Forum News - Investor Hub
Yahoo View PMCB Stock Mentions - Yahoo! Message Board Seeking Alpha View PMCB Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PMCB - SECform4.com Insider Cow View Insider Transactions for PMCB - Insider Cow
CNBC View PMCB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PMCB - OTC Markets
Yahoo View Insider Transactions for PMCB - Yahoo! Finance NASDAQ View Institutional Holdings for PMCB - NASDAQ


Stock Charts

FinViz View PMCB Stock Insight & Charts - FinViz.com StockCharts View PMCB Investment Charts - StockCharts.com
BarChart View PMCB Stock Overview & Charts - BarChart Trading View View PMCB User Generated Charts - Trading View




Latest Financial News for PMCB


PharmaCyte Biotech Engages cGMP Validation to Assist in Preparation of IND for Pancreatic Cancer Trial
Posted on Tuesday December 04, 2018

PharmaCyte Biotech, Inc. (PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has engaged cGMP Validation L.L.C. (cGMP Validation) to assist in the preparation of the Investigational New Drug application (IND) that must be submitted to and approved by the U.S. Food and Drug Administration (FDA) before PharmaCyte can begin its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC). cGMP Validation is playing a pivotal role for PharmaCyte and will continue to do so as it moves forward with the preparation of its IND.


PharmaCyte Biotech Completes Report of FDA Required Study Assessing Safety of Placement of Its Pancreatic Cancer Product
Posted on Thursday November 15, 2018

PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully completed a U.S. Food and Drug Administration (FDA) required formal report on the safety studies conducted by Bavarian Nordic using a pig model that were undertaken before the first clinical trial in humans using cellulose-based capsules that contain live genetically altered cells which activate the anticancer prodrug ifosfamide. The voluminous information contained in the formal report is another complicated Investigational New Drug Application (IND) component requested by the FDA to be included in the IND before the start of the clinical trial for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).


PharmaCyte Biotech Selects Medpace as CRO for Its Clinical Trial in Pancreatic Cancer
Posted on Tuesday November 06, 2018

PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has selected Medpace, Inc. as the Contract Research Organization (CRO) to conduct PharmaCyte’s clinical trial in locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).


PharmaCyte Biotech Announces Publication of United States Patent Application for Cancer Therapies
Posted on Tuesday October 30, 2018

PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its Patent Application titled “Encapsulated Cells Producing Cytochrome P450 and Methods of Use Thereof,” which covers a targeted therapy to treat solid cancerous tumors, was published in the United States on September 27, 2018, (Publication No. US 2018/0271794 A1). Unlike the previously announced PCT Application, which was international in nature, this Patent Application is specific to the United States.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.